Facteurs pronostiques dans le myélome multiple: analyse critique à partir de quatre-vingt-quatre patients = Prognostic factors in multiple myeloma-critical analysis in eighty-four patientsBENITEZ, O; DE GRAMONT, A; HUBERT, D et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 40, pp 2791-2794, issn 0037-1777Article

Multiple myeloma in a pair of monozygotic twins: the first reported caseJUDSON, I. R; WILTSHAW, E; NEWLAND, A. C et al.British journal of haematology. 1985, Vol 60, Num 3, pp 551-554, issn 0007-1048Article

Incompletë pyroglobulin-gamma disease in a patient with osteosclerotic myelomaRUIZ-ARGUELLES, A; VALLS-DE-RUIZ, M; DOMINGUEZ-BARRANCO, A et al.Scandinavian journal of haematology. 1984, Vol 33, Num 4, pp 351-355, issn 0036-553XArticle

A study of certain functional parameters of monocytes from patients with multiple myeloma: comparison with monocytes from healthy individualsBLOM, J; NIELSEN, H; OLESEN LARSEN, S et al.Scandinavian journal of haematology. 1984, Vol 33, Num 5, pp 425-431, issn 0036-553XArticle

Irradiation hémi-corporelle et myélome = Helf body irradiation and myelomeLACROZE, M; DUTOU, L.Journal de médecine de Lyon (Lyon. 1864). 1985, Vol 66, Num 1409, pp 579-581, issn 0021-7883Article

Le myélome multiple chez les sujets âgés de plus de quatre-vingts ans: facteurs pronostiques = Multiple myeloma in patients above eighty years of age. Pronostic factorsPASCAUD, F; TAVERNIER, C; LAVAULT, J. F et al.La Semaine des hôpitaux de Paris. 1989, Vol 65, Num 42, pp 2577-2581, issn 0037-1777, 5 p.Article

Treatment of multiple myeloma with recombinant α-interferonQUESADA, J. R; ALEXANIAN, R; HAWKINS, M et al.Blood. 1986, Vol 67, Num 2, pp 275-278, issn 0006-4971Article

Myélome multiple = Multiple myelomaSOLAL-CELIGNY, P.Revue de médecine et d'internat. 1985, Num 5, pp 11-14Article

Heterochromatic variants and their association with neoplasias. III: Multiple myelomaRANNI, N. S. M; LABAL DE VINUESA, M; MUDRY DE PARGAMENT, M et al.Cancer genetics and cytogenetics. 1987, Vol 28, Num 1, pp 101-105, issn 0165-4608Article

Contestation d'une critique concernant la comparaison de deux classifications pronostiques du myélome multiple = Contestation of a criticism about the comparison of two pronostic staging systems for multiple myelomaPESCE, A; CASSUTO, J. P; GRISOT, C et al.Nouvelle revue française d'hématologie. 1984, Vol 26, Num 6, issn 0029-4810, 401Article

Ten-year survival in multiple myeloma : report of two cases and review of the literatureROSNER, F; GRÜNWALD, H. W; KALMAN, A. C et al.New York State journal of medicine. 1992, Vol 92, Num 7, pp 316-318, issn 0028-7628Article

Myélome multiple : approches thérapeutiques actuelles = Multiple myeloma: current therapeutic approachesTROUSSARD, X; BAUDUER, F; LEPORRIER, M et al.Bulletin du cancer. 1992, Vol 79, Num 3, pp 231-242, issn 0007-4551Article

Le myélome à chaînes légères = Light chain myelomaFOURNIER-LEMAIRE, M; VAN DEN ABEELE, P; MULLER, K et al.LARC médical. 1985, Vol 5, Num 7, pp 381-384, issn 0242-9462Article

Perineal infiltration by plasma cells in a patient with multiple myeloma: a rare presentation = Infiltration périnéale de plasmocytes chez un malade atteint de myélome multiple: une présentation rareLEWINSKI, U. H; BAYER, I; TURANI, H et al.Diseases of the colon & rectum. 1984, Vol 27, Num 7, pp 479-480, issn 0012-3706Article

Hyperviscosity syndrome in IgE myelomaPROCTOR, S. J; CHAWLA, S. L; BIRD, A. G et al.British medical journal (1857). 1984, Vol 289, Num 6452, issn 0007-1447, 1112Article

Myélome multiple. Physiopathologie, diagnostic, évolution et pronostic, principes du traitement = Multiple myeloma. Physiopathology, diagnosis, evolution and prognostis, treatmentLE LOET, X.La Revue du praticien (Paris). 1989, Vol 39, Num 15, pp 1353-1358, issn 0035-2640Article

Mieloma multiple con lesiones cutaneas específicas = Myélome multiple avec lésions cutanées spécifiques = Multiple myeloma with specific cutaneous lesionsMANRIQUE MARTINEZ, P; GIL MARTIN, R; IGLESIAS DIEZ, L et al.Actas dermo-sifiliográficas (Ed. impresa). 1987, Vol 78, Num 2, pp 91-93, issn 0001-7310Article

Survenue d'une sulfhémoglobinémie 10 ans après l'apparition d'un myélome = Sulfmethoglobinaemia onset 10 years following the detection of myelomaPIERON, R; GRATEAU, G; MAFART, Y et al.La Presse médicale (1983). 1985, Vol 1, Num 1, pp 46-47, issn 0755-4982Article

Myeloma therapyBRANDER, L. J; ISRAELS, L. G.Lancet (British edition). 1992, Vol 339, Num 8799, issn 0140-6736, p. 992Article

Marrow fibrosis in myeloma: improvement by alkylatingPATTERSON, K. G; TRELEAVEN, J. G; ZUIABLE, A et al.Clinical and laboratory haematology. 1988, Vol 10, Num 2, pp 221-224, issn 0141-9854Article

The effect of BM 12.531 (azimexon) on natural killer cell activity in myeloma patients = Effet du BM 12.531 (azimexon) sur l'activité des cellules tueuses naturelles des patients atteints de myélomePETER, H. H; DZIUBA-TRABER, H; BOERNER, D et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 3, pp 353-359, issn 0277-5379Article

Simultaneous occurrence of multiple myeloma and acute myeloblastic leukemia: fact or myth?ROSNER, F; GRUNWALD, H. W.The American journal of medicine. 1984, Vol 76, Num 5, pp 891-899, issn 0002-9343Article

Pseudohyperphosphataemia in patients with multiple myelomaMCCLURE, D; LAI, L. C; CORNELL, C et al.Journal of clinical pathology. 1992, Vol 45, Num 8, pp 731-732, issn 0021-9746Article

Multidrug-resistant myeloma : laboratory and clinical effects of verapamil as a chemosensitizerSALMON, S. E; DALTON, W. S; GROGAN, T. M et al.Blood. 1991, Vol 78, Num 1, pp 44-50, issn 0006-4971Article

Karyotypic evolution in multiple myelomaMACKENZIE, M. R; LEWIS, J. P.Cancer genetics and cytogenetics. 1985, Vol 17, Num 4, pp 301-305, issn 0165-4608Article